172701-61-0

Basic information

• Product Name: N-[4-({5-[1-(3-chlorophenyl)-5-{(E)-[4-(dimethylamino)phenyl]diazenyl}-4-methoxy-1H-pyrazol-3-yl]-1,3,4-thiadiazol-2-yl}sulfamoyl)phenyl]acetamide
• CAS NO: 172701-61-0
• Molecular Formula: C₂₈H₂₆ClN₉O₄S₂
• Molecular Weight: 652.1469
• Mol File: 172701-61-0.mol
• Article Data: 1

Chemical Properties

• Density: 1.48g/cm³
• Refractive Index: 1.712
• CAS DataBase Reference: N-[4-({5-[1-(3-chlorophenyl)-5-{(E)-[4-(dimethylamino)phenyl]diazenyl}-4-methoxy-1H-pyrazol-3-yl]-1,3,4-thiadiazol-2-yl}sulfamoyl)phenyl]acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[4-({5-[1-(3-chlorophenyl)-5-{(E)-[4-(dimethylamino)phenyl]diazenyl}-4-methoxy-1H-pyrazol-3-yl]-1,3,4-thiadiazol-2-yl}sulfamoyl)phenyl]acetamide(172701-61-0)
• EPA Substance Registry System: N-[4-({5-[1-(3-chlorophenyl)-5-{(E)-[4-(dimethylamino)phenyl]diazenyl}-4-methoxy-1H-pyrazol-3-yl]-1,3,4-thiadiazol-2-yl}sulfamoyl)phenyl]acetamide(172701-61-0)

Safety Data

• Hazardous Substances Data: 172701-61-0(Hazardous Substances Data)

Upstream product

• 172701-58-5 5-[1-(3-Chloro-phenyl)-5-(4-dimethylamino-phenylazo)-4-methoxy-1H-pyrazol-3-yl]-[1,3,4]thiadiazol-2-ylamine 
• 121-60-8 p-acetylaminobenzenesulfonyl chloride 
• 172701-55-2 C₂₀H₂₁ClN₈O₂S 
• 172701-49-4 1-(3-Chloro-phenyl)-5-(4-dimethylamino-phenylazo)-4-methoxy-1H-pyrazole-3-carboxylic acid ethyl ester 
• 172701-52-9 1-(3-Chloro-phenyl)-5-(4-dimethylamino-phenylazo)-4-methoxy-1H-pyrazole-3-carboxylic acid hydrazide 

Relevant articles and documents

Synthesis and pharmacological evaluation of some novel 5-(pyrazol-3-yl)thiadiazole and oxadiazole derivatives as potential hypoglycemic agents

Four series of 5-(pyrazol-3-yl)thiadiazole and oxadiazole derivatives (Va-c, VIa-c, VIIIa-c, IXa-c) have been synthesized from 5-arylazo-3-carbethoxy-4-methoxy-1-phenylpyrazole (Ia-c) with a view to investigate their pharmacological activity. The structure of the synthesized products was inferred from elemental and spectral data. The hypoglycemic effect, antimicrobial activity and toxicity of these potential chemotherapeutic agents were evaluated. Nineteen of these products were effective, when administered at an oral dose of 100 mg/kg body weight in inducing a marked reduction in blood glucose level.